Targeting the CD47/TSP-1 Axis: A Promising Strategy for Patients with Ovarian Cancer (OC) That Relapses on PARP Inhibitors (Parpi).
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined